2-[3-acetyl-5-(3-methylbutyl)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-methylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-[3-acetyl-5-(2-methylpropoxy)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-ylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-yloxyindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide

C136H202N20O17 — CID 167570723

IUPAC2-[3-acetyl-5-(3-methylbutyl)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-methylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-[3-acetyl-5-(2-methylpropoxy)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-ylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-yloxyindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide
SMILESCC(=O)c1nn(CC(=O)N(C)C2CCCCCCCCCCNC2=O)c2ccc(C(C)C)cc12.CC(=O)c1nn(CC(=O)N(C)C2CCCCCCCCCCNC2=O)c2ccc(C)cc12.CC(=O)c1nn(CC(=O)N(C)C2CCCCCCCCCCNC2=O)c2ccc(CCC(C)C)cc12.CC(=O)c1nn(CC(=O)N(C)C2CCCCCCCCCCNC2=O)c2ccc(OC(C)C)cc12.CC(=O)c1nn(CC(=O)N(C)C2CCCCCCCCCCNC2=O)c2ccc(OCC(C)C)cc12
InChIInChI=1S/C29H44N4O3.C28H42N4O4.C27H40N4O4.C27H40N4O3.C25H36N4O3/c1-21(2)14-15-23-16-17-25-24(19-23)28(22(3)34)31-33(25)20-27(35)32(4)26-13-11-9-7-5-6-8-10-12-18-30-29(26)36;1-20(2)19-36-22-14-15-24-23(17-22)27(21(3)33)30-32(24)18-26(34)31(4)25-13-11-9-7-5-6-8-10-12-16-29-28(25)35;1-19(2)35-21-14-15-23-22(17-21)26(20(3)32)29-31(23)18-25(33)30(4)24-13-11-9-7-5-6-8-10-12-16-28-27(24)34;1-19(2)21-14-15-23-22(17-21)26(20(3)32)29-31(23)18-25(33)30(4)24-13-11-9-7-5-6-8-10-12-16-28-27(24)34;1-18-13-14-21-20(16-18)24(19(2)30)27-29(21)17-23(31)28(3)22-12-10-8-6-4-5-7-9-11-15-26-25(22)32/h16-17,19,21,26H,5-15,18,20H2,1-4H3,(H,30,36);14-15,17,20,25H,5-13,16,18-19H2,1-4H3,(H,29,35);14-15,17,19,24H,5-13,16,18H2,1-4H3,(H,28,34);14-15,17,19,24H,5-13,16,18H2,1-4H3,(H,28,34);13-14,16,22H,4-12,15,17H2,1-3H3,(H,26,32)
InChIKeyFWINNAGLBJZBTP-UHFFFAOYSA-N
MW2389.23 g/mol
LogP23.38
Rot. Bonds29

About 2-[3-acetyl-5-(3-methylbutyl)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-methylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-[3-acetyl-5-(2-methylpropoxy)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-ylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-yloxyindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide

2-[3-acetyl-5-(3-methylbutyl)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-methylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-[3-acetyl-5-(2-methylpropoxy)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-ylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-yloxyindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide (PubChem CID 167570723) has the molecular formula C136H202N20O17 and a molecular weight of 2389.23 g/mol. Its IUPAC name is 2-[3-acetyl-5-(3-methylbutyl)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-methylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-[3-acetyl-5-(2-methylpropoxy)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-ylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-yloxyindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide.

Molecular Properties

Compound Name2-[3-acetyl-5-(3-methylbutyl)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-methylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-[3-acetyl-5-(2-methylpropoxy)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-ylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-yloxyindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide
PubChem CID167570723
Molecular FormulaC136H202N20O17
Molecular Weight2389.23 g/mol
Exact Mass2387.56
IUPAC Name2-[3-acetyl-5-(3-methylbutyl)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-methylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-[3-acetyl-5-(2-methylpropoxy)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-ylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-yloxyindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide
SMILESCC(=O)c1nn(CC(=O)N(C)C2CCCCCCCCCCNC2=O)c2ccc(C(C)C)cc12.CC(=O)c1nn(CC(=O)N(C)C2CCCCCCCCCCNC2=O)c2ccc(C)cc12.CC(=O)c1nn(CC(=O)N(C)C2CCCCCCCCCCNC2=O)c2ccc(CCC(C)C)cc12.CC(=O)c1nn(CC(=O)N(C)C2CCCCCCCCCCNC2=O)c2ccc(OC(C)C)cc12.CC(=O)c1nn(CC(=O)N(C)C2CCCCCCCCCCNC2=O)c2ccc(OCC(C)C)cc12
InChIInChI=1S/C29H44N4O3.C28H42N4O4.C27H40N4O4.C27H40N4O3.C25H36N4O3/c1-21(2)14-15-23-16-17-25-24(19-23)28(22(3)34)31-33(25)20-27(35)32(4)26-13-11-9-7-5-6-8-10-12-18-30-29(26)36;1-20(2)19-36-22-14-15-24-23(17-22)27(21(3)33)30-32(24)18-26(34)31(4)25-13-11-9-7-5-6-8-10-12-16-29-28(25)35;1-19(2)35-21-14-15-23-22(17-21)26(20(3)32)29-31(23)18-25(33)30(4)24-13-11-9-7-5-6-8-10-12-16-28-27(24)34;1-19(2)21-14-15-23-22(17-21)26(20(3)32)29-31(23)18-25(33)30(4)24-13-11-9-7-5-6-8-10-12-16-28-27(24)34;1-18-13-14-21-20(16-18)24(19(2)30)27-29(21)17-23(31)28(3)22-12-10-8-6-4-5-7-9-11-15-26-25(22)32/h16-17,19,21,26H,5-15,18,20H2,1-4H3,(H,30,36);14-15,17,20,25H,5-13,16,18-19H2,1-4H3,(H,29,35);14-15,17,19,24H,5-13,16,18H2,1-4H3,(H,28,34);14-15,17,19,24H,5-13,16,18H2,1-4H3,(H,28,34);13-14,16,22H,4-12,15,17H2,1-3H3,(H,26,32)
InChIKeyFWINNAGLBJZBTP-UHFFFAOYSA-N
XLogP23.38
TPSA439.96 Ų
H-Bond Donors5
H-Bond Acceptors27
Rotatable Bonds29
Heavy Atoms173
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002389.23
LogP ≤ 523.38
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1027

Analyze 2-[3-acetyl-5-(3-methylbutyl)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-methylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-[3-acetyl-5-(2-methylpropoxy)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-ylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-yloxyindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[3-acetyl-5-(3-methylbutyl)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-methylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-[3-acetyl-5-(2-methylpropoxy)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-ylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-yloxyindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide?
The IUPAC name of 2-[3-acetyl-5-(3-methylbutyl)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-methylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-[3-acetyl-5-(2-methylpropoxy)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-ylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-yloxyindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide (CID 167570723) is 2-[3-acetyl-5-(3-methylbutyl)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-methylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-[3-acetyl-5-(2-methylpropoxy)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-ylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-yloxyindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide.
What is the SMILES notation for 2-[3-acetyl-5-(3-methylbutyl)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-methylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-[3-acetyl-5-(2-methylpropoxy)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-ylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-yloxyindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide?
The canonical SMILES for 2-[3-acetyl-5-(3-methylbutyl)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-methylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-[3-acetyl-5-(2-methylpropoxy)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-ylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-yloxyindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide is CC(=O)c1nn(CC(=O)N(C)C2CCCCCCCCCCNC2=O)c2ccc(C(C)C)cc12.CC(=O)c1nn(CC(=O)N(C)C2CCCCCCCCCCNC2=O)c2ccc(C)cc12.CC(=O)c1nn(CC(=O)N(C)C2CCCCCCCCCCNC2=O)c2ccc(CCC(C)C)cc12.CC(=O)c1nn(CC(=O)N(C)C2CCCCCCCCCCNC2=O)c2ccc(OC(C)C)cc12.CC(=O)c1nn(CC(=O)N(C)C2CCCCCCCCCCNC2=O)c2ccc(OCC(C)C)cc12.
What is the InChIKey of 2-[3-acetyl-5-(3-methylbutyl)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-methylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-[3-acetyl-5-(2-methylpropoxy)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-ylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-yloxyindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide?
The InChIKey is FWINNAGLBJZBTP-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H44N4O3.C28H42N4O4.C27H40N4O4.C27H40N4O3.C25H36N4O3/c1-21(2)14-15-23-16-17-25-24(19-23)28(22(3)34)31-33(25)20-27(35)32(4)26-13-11-9-7-5-6-8-10-12-18-30-29(26)36;1-20(2)19-36-22-14-15-24-23(17-22)27(21(3)33)30-32(24)18-26(34)31(4)25-13-11-9-7-5-6-8-10-12-16-29-28(25)35;1-19(2)35-21-14-15-23-22(17-21)26(20(3)32)29-31(23)18-25(33)30(4)24-13-11-9-7-5-6-8-10-12-16-28-27(24)34;1-19(2)21-14-15-23-22(17-21)26(20(3)32)29-31(23)18-25(33)30(4)24-13-11-9-7-5-6-8-10-12-16-28-27(24)34;1-18-13-14-21-20(16-18)24(19(2)30)27-29(21)17-23(31)28(3)22-12-10-8-6-4-5-7-9-11-15-26-25(22)32/h16-17,19,21,26H,5-15,18,20H2,1-4H3,(H,30,36);14-15,17,20,25H,5-13,16,18-19H2,1-4H3,(H,29,35);14-15,17,19,24H,5-13,16,18H2,1-4H3,(H,28,34);14-15,17,19,24H,5-13,16,18H2,1-4H3,(H,28,34);13-14,16,22H,4-12,15,17H2,1-3H3,(H,26,32).
What are the key properties of 2-[3-acetyl-5-(3-methylbutyl)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-methylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-[3-acetyl-5-(2-methylpropoxy)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-ylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-yloxyindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide?
2-[3-acetyl-5-(3-methylbutyl)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-methylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-[3-acetyl-5-(2-methylpropoxy)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-ylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-yloxyindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide has a molecular weight of 2389.23 g/mol, XLogP of 23.38, 29 rotatable bonds, 5 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-acetyl-5-(3-methylbutyl)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-methylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-[3-acetyl-5-(2-methylpropoxy)indazol-1-yl]-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-ylindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide;2-(3-acetyl-5-propan-2-yloxyindazol-1-yl)-N-methyl-N-(2-oxo-azacyclotridec-3-yl)acetamide is sourced from PubChem (CID 167570723), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).